Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer

C. Sarroca, Adriana Della Valle, R. Fresco, E. Renkonen, P. Peltömaki, Henry T. Lynch

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Few studies have investigated the frequency of hereditary non-polyposis colorectal cancer (HNPCC) in patients with colorectal cancer (CRC), and these have shown marked geographic variations. The aim of this study was to estimate the frequency of HNPCC in a cohort of Uruguayan CRC patients. We included all patients operated consecutively for CRC in the Hospital Central de las Fuerzas Armadas (Uruguay) between 1987 and 2003. Cases were classified into three groups: (i) those fulfilling Amsterdam criteria; (ii) those not fulfilling Amsterdam criteria but considered as a population at increased risk of cancer; and (iii) sporadic CRC. Genetic analysis to detect point mutations in hMLH/hMSH2/hMSH6 genes was performed in group 1 patients. Cases not showing mutations were tested by multiplex ligation-dependent probe amplification. Among 461 patients, group 1 represented 2.6%, group 2 represented 5.6%, and sporadic cases 91.8%. hMLH1/hMSH2/hMSH6 mutations were found in 25% of cases classified as HNPCC (two in hMLH1 and one in hMSH2). No mutations were detected in hMSH6 gene. The proportion of CRC patients that fulfilled Amsterdam criteria agrees with other reports. However, the percentage of HNPCC cases with identified mutations (25%) may be lower than that reported from other populations. This may reflect, among other possible causes, a different genetic profile in the Uruguayan population.

Original languageEnglish
Pages (from-to)80-87
Number of pages8
JournalClinical Genetics
Volume68
Issue number1
DOIs
StatePublished - Jul 2005

Fingerprint

Colorectal Neoplasms
Mutation
Uruguay
Cancer Care Facilities
Multiplex Polymerase Chain Reaction
Point Mutation
Population
Genes
Neoplasms

All Science Journal Classification (ASJC) codes

  • Genetics(clinical)
  • Genetics

Cite this

Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer. / Sarroca, C.; Della Valle, Adriana; Fresco, R.; Renkonen, E.; Peltömaki, P.; Lynch, Henry T.

In: Clinical Genetics, Vol. 68, No. 1, 07.2005, p. 80-87.

Research output: Contribution to journalArticle

Sarroca, C. ; Della Valle, Adriana ; Fresco, R. ; Renkonen, E. ; Peltömaki, P. ; Lynch, Henry T. / Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer. In: Clinical Genetics. 2005 ; Vol. 68, No. 1. pp. 80-87.
@article{6339eced5e1d4fd2811793560d92b55f,
title = "Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer",
abstract = "Few studies have investigated the frequency of hereditary non-polyposis colorectal cancer (HNPCC) in patients with colorectal cancer (CRC), and these have shown marked geographic variations. The aim of this study was to estimate the frequency of HNPCC in a cohort of Uruguayan CRC patients. We included all patients operated consecutively for CRC in the Hospital Central de las Fuerzas Armadas (Uruguay) between 1987 and 2003. Cases were classified into three groups: (i) those fulfilling Amsterdam criteria; (ii) those not fulfilling Amsterdam criteria but considered as a population at increased risk of cancer; and (iii) sporadic CRC. Genetic analysis to detect point mutations in hMLH/hMSH2/hMSH6 genes was performed in group 1 patients. Cases not showing mutations were tested by multiplex ligation-dependent probe amplification. Among 461 patients, group 1 represented 2.6{\%}, group 2 represented 5.6{\%}, and sporadic cases 91.8{\%}. hMLH1/hMSH2/hMSH6 mutations were found in 25{\%} of cases classified as HNPCC (two in hMLH1 and one in hMSH2). No mutations were detected in hMSH6 gene. The proportion of CRC patients that fulfilled Amsterdam criteria agrees with other reports. However, the percentage of HNPCC cases with identified mutations (25{\%}) may be lower than that reported from other populations. This may reflect, among other possible causes, a different genetic profile in the Uruguayan population.",
author = "C. Sarroca and {Della Valle}, Adriana and R. Fresco and E. Renkonen and P. Pelt{\"o}maki and Lynch, {Henry T.}",
year = "2005",
month = "7",
doi = "10.1111/j.1399-0004.2005.00458.x",
language = "English",
volume = "68",
pages = "80--87",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer

AU - Sarroca, C.

AU - Della Valle, Adriana

AU - Fresco, R.

AU - Renkonen, E.

AU - Peltömaki, P.

AU - Lynch, Henry T.

PY - 2005/7

Y1 - 2005/7

N2 - Few studies have investigated the frequency of hereditary non-polyposis colorectal cancer (HNPCC) in patients with colorectal cancer (CRC), and these have shown marked geographic variations. The aim of this study was to estimate the frequency of HNPCC in a cohort of Uruguayan CRC patients. We included all patients operated consecutively for CRC in the Hospital Central de las Fuerzas Armadas (Uruguay) between 1987 and 2003. Cases were classified into three groups: (i) those fulfilling Amsterdam criteria; (ii) those not fulfilling Amsterdam criteria but considered as a population at increased risk of cancer; and (iii) sporadic CRC. Genetic analysis to detect point mutations in hMLH/hMSH2/hMSH6 genes was performed in group 1 patients. Cases not showing mutations were tested by multiplex ligation-dependent probe amplification. Among 461 patients, group 1 represented 2.6%, group 2 represented 5.6%, and sporadic cases 91.8%. hMLH1/hMSH2/hMSH6 mutations were found in 25% of cases classified as HNPCC (two in hMLH1 and one in hMSH2). No mutations were detected in hMSH6 gene. The proportion of CRC patients that fulfilled Amsterdam criteria agrees with other reports. However, the percentage of HNPCC cases with identified mutations (25%) may be lower than that reported from other populations. This may reflect, among other possible causes, a different genetic profile in the Uruguayan population.

AB - Few studies have investigated the frequency of hereditary non-polyposis colorectal cancer (HNPCC) in patients with colorectal cancer (CRC), and these have shown marked geographic variations. The aim of this study was to estimate the frequency of HNPCC in a cohort of Uruguayan CRC patients. We included all patients operated consecutively for CRC in the Hospital Central de las Fuerzas Armadas (Uruguay) between 1987 and 2003. Cases were classified into three groups: (i) those fulfilling Amsterdam criteria; (ii) those not fulfilling Amsterdam criteria but considered as a population at increased risk of cancer; and (iii) sporadic CRC. Genetic analysis to detect point mutations in hMLH/hMSH2/hMSH6 genes was performed in group 1 patients. Cases not showing mutations were tested by multiplex ligation-dependent probe amplification. Among 461 patients, group 1 represented 2.6%, group 2 represented 5.6%, and sporadic cases 91.8%. hMLH1/hMSH2/hMSH6 mutations were found in 25% of cases classified as HNPCC (two in hMLH1 and one in hMSH2). No mutations were detected in hMSH6 gene. The proportion of CRC patients that fulfilled Amsterdam criteria agrees with other reports. However, the percentage of HNPCC cases with identified mutations (25%) may be lower than that reported from other populations. This may reflect, among other possible causes, a different genetic profile in the Uruguayan population.

UR - http://www.scopus.com/inward/record.url?scp=20944443555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20944443555&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0004.2005.00458.x

DO - 10.1111/j.1399-0004.2005.00458.x

M3 - Article

VL - 68

SP - 80

EP - 87

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 1

ER -